Steinhart Richard I

Average Profitability
31.13%
Insider Buys Quantity
6
Insider Buys Sum
$33,996.90
Insider Sells Quantity
8
Insider Sells Sum
$385,561.69

Insider Activity of Steinhart Richard I

According to the SEC Form 4 filings, Steinhart Richard I, being in a position of

  1. Chief Financial Officer at BioXcel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9549 shares for $7,685,
    over all time since 2018-11-29, has bought 3000 shares for $15,200, and sold 24133 shares for $385,562.

The largest purchase of all time was on 2016-04-14 and amounted to 5000 shares of Actinium Pharmaceuticals, Inc. for $10,050.

The largest sale of all time was on 2021-02-01 and amounted to 7500 shares of BioXcel Therapeutics, Inc. for $201,375.

Biography of Steinhart Richard I

No biography is available at this moment.

2024-12-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
577
0.0011%
$0.36$207-4.01%
2024-10-03SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
7,175
0.0181%
$0.55$3,946-6.38%
2024-09-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
356
0.0009%
$0.69$246-14.19%
2024-06-17SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
372
0.0009%
$1.26$470-55.26%
2024-04-04SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
1,069
0.0031%
$2.63$2,817-73.71%
2023-05-15SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
5,000
0.0174%
$27.17$135,864-87.99%
2023-03-15SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
2,084
0.0072%
$19.50$40,638-79.74%
2021-02-01SaleBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
7,500
0.0159%
$26.85$201,375-40.89%
2018-12-03PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
1,000
0.007%
$5.20$5,200+79.76%
2018-11-30PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
1,000
0.0071%
$5.00$5,000+89.65%
2018-11-29PurchaseBioXcel Therapeutics, Inc.
BTAI
Chief Financial Officer
1,000
0.0073%
$5.00$5,000+93.45%
2016-04-14PurchaseActinium Pharmaceuticals, Inc.
ATNM
director
5,000
0.0108%
$2.01$10,050-25.37%
2013-06-25PurchaseSTRATA Skin Sciences, Inc.
SSKN
Chief Financial Officer
3,000
0.007%
$0.81$2,427-14.34%
2010-08-12PurchaseSTRATA Skin Sciences, Inc.
SSKN
Chief Financial Officer
1,000
0.004%
$6.32$6,320-49.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.